Background: With the transition to hydrofluoroalkane-134a propellants in metered dose inhalers, it is important to consider the efficacy and safety profiles of formulations containing inhaled ...

HFA’s Rumblefish is part of the music services division of SESAC Music Group. Click here for more on the deal with ByteDance… ...

Beclomethasone dipropionate HFA-MDI, ciclesonide HFA-MDI, flunisolide HFA-MDI, and fluticasone propionate HFA-MDI all have FDA-approved labeling for twice-daily dosing.

Another open-label study compared equal microgram amounts of beclomethasone dipropionate HFA-MDI (n = 20) with fluticasone propionate CFC-MDI (n = 10) in adults with poorly controlled asthma ...

Adams NP, Bestall JC, Jones P. Beclomethasone at different doses for chronic asthma. Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD002879. DOI: 10.1002/14651858.CD002879. Bukti ...

为解决高全球变暖潜能值(GWP)推进剂HFA-134a在加压定量吸入器(pMDI)中的环境问题，研究人员开展了一项关于低GWP推进剂HFA-152a对二丙酸倍氯米松(BDP)药代动力学影响的随机双盲交叉研究。结果显示，200 μg/喷剂量的HFA-152a与HFA-134a在肺可用性(Cmax /AUC0-t )和全身暴露量(B17MP)上均满足生物等效性标准，为环保 ...

b Beclomethasone dipropionate and ciclesonide are prodrugs that are activated in the lung to their active metabolites beclomethasone 17-monopropionate and desciclesonide, respectively c These values ...

HFA’s ongoing commitment to constructive engagement Notwithstanding this litigation against the NHI Act, the HFA remains committed to constructive engagement with Government and its healthcare ...

低全球变暖潜能值推进剂HFA-152a对支气管收缩和黏膜纤毛清除功能的安全性评估 《Pulmonary Pharmacology & Therapeutics》：The low global warming potential propellant HFA-152a does not induce bronchoconstriction or impair mucociliary ...

CARMICHAEL, Calif. — Home Furnishings Assn. CEO Shannon Williams is no longer with the industry organization. In a June 3 letter obtained by sister publication Furniture Today, HFA board President ...